Appendix A
Agenda

Ethical and Legal Considerations in Mitigating Pandemic Disease

PAHO Headquarters—Conference Room A

525 23rd Street, NW

Washington, D.C.

September 19-20, 2006


AGENDA

Tuesday, September 19, 2006

8:30 a.m.

Continental Breakfast

9:00 a.m.

Welcome and Opening Remarks

Stanley M. Lemon, M.D., Chair,

Forum on Microbial Threats

9:15–10:00 a.m.

KEYNOTE ADDRESS: “Past as Prologue?”

David Heymann, M.D.,

World Health Organization

10:00–10:15 a.m.

Discussion



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 203
Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary Appendix A Agenda Ethical and Legal Considerations in Mitigating Pandemic Disease PAHO Headquarters—Conference Room A 525 23rd Street, NW Washington, D.C. September 19-20, 2006 AGENDA Tuesday, September 19, 2006 8:30 a.m. Continental Breakfast 9:00 a.m. Welcome and Opening Remarks Stanley M. Lemon, M.D., Chair, Forum on Microbial Threats 9:15–10:00 a.m. KEYNOTE ADDRESS: “Past as Prologue?” David Heymann, M.D., World Health Organization 10:00–10:15 a.m. Discussion

OCR for page 203
Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary Session I: Understanding the Challenges of the Future by Examining the Past: Influenza/Smallpox/SARS Moderator: Ruth Berkelman, M.D., Emory University, Rollins School of Public Health 10:15–11:00 a.m. Contemplating Pandemics: The Role of Historical Inquiry in Developing Pandemic-Mitigation Strategies for the Twenty-First Century Howard Markel, M.D., University of Michigan 11:00–11:45 a.m. The Smallpox Eradication Campaign D.A. Henderson, M.D., Center for Biosecurity, University of Pittsburgh Medical Center 11:45 a.m.–12:30 p.m. Lessons from SARS David Heymann, M.D., World Health Organization 12:30–1:00 p.m. Session I Q&A 1:00–1:45 p.m. LUNCH Session II: Domestic, Regional, and International Preparedness Planning Moderator: P. Frederick Sparling, M.D., Vice Chair, Forum on Microbial Threats 1:45–2:30 p.m. U.S. Government Preparedness Plans Bruce Gellin, M.D., Office of the Secretary, Department of Health and Human Services 2:30–3:15 p.m. Regional Planning Efforts Oscar J. Mujica, M.D., M.P.H., P.H.E., Pan American Health Organization 3:15–3:45 p.m. Q&A 3:45–4:00 p.m. BREAK 4:00–4:45 p.m. Ethical Considerations in International Preparedness Planning Efforts Alexander Morgan Capron, University of Southern California

OCR for page 203
Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary 4:45–5:15 p.m. Open Discussion of Session II 5:15–6:00 p.m. Open Discussion of Day 1 6:00 p.m. Adjourn Wednesday, September 20, 2006 8:00 a.m. Continental Breakfast 8:30 a.m. Opening Remarks/Summary of Day 1: Margaret A. Hamburg, M.D., Vice Chair, Forum on Microbial Threats Session III: Disease Mitigation Strategies–Quarantine, Containment and Modeling Moderator: Gary Roselle, M.D., Program Director for Infectious Diseases, Department of Veterans Affairs Central Office 8:45–9:30 a.m. Public Health and Ethical Considerations in Planning for Quarantine Martin Cetron, M.D., Centers for Disease Control and Prevention 9:30–10:15 a.m. Preparing for Pandemic Influenza: Legal and Ethical Challenges Lawrence Gostin, J.D., Georgetown University School of Law 10:15–10:30 a.m. Discussion 10:30–11:15 a.m. The Role of Modeling in Infectious Disease Mitigation and Containment Joshua Epstein, Ph.D., The Brookings Institution 11:15–11:45 a.m. Discussion Panel: Timothy C. Germann, Ph.D., Los Alamos National Laboratory James LeDuc, M.D., Centers for Disease Control and Prevention Victoria Sutton, J.D., Ph.D., Texas Tech University School of Law

OCR for page 203
Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary 11:45 a.m.–12:30 p.m. Lunch 12:30–1:30 p.m. Luncheon Remarks Harvey V. Fineberg, M.D., Ph.D., President, Institute of Medicine Session IV: Ethical Issues in Pandemic Planning and Response Moderator: Stanley M. Lemon, M.D., Chair, Forum on Microbial Threats 1:30–2:15 p.m. Intensive Care Unit Triage During an Influenza Pandemic: The Need for Specific Clinical Guidelines Bernard Lo, M.D., University of California, San Francisco 2:15–3:00 p.m. Social Justice and Pandemic Planning and Response Ruth Faden, Ph.D., Berman Bioethics Institute, Johns Hopkins University 3:00–3:45 p.m. Discussion Panel: Steven Bice, Battelle, Atlanta, Georgia D.A. Henderson, M.D., Center for Biosecurity, University of Pittsburgh Medical Center Shelley Hearne, D.P.H., Johns Hopkins University 3:45–4:30 p.m. Open Discussion 4:30–4:45 p.m. Closing Remarks/Adjourn